ANNASTASIAH MUDIWA MHAKA, PH.D. Personal email: am11bf220@westpost.

net (410) 693-9804 SUMMARY OF QUALIFICATIONS Analytical "go-to" thinker extremely dedicated and motivated individual with str ong teaming ability. Eager to apply technical and business skills toward develo ping strategic solutions within a progressive life sciences venture. PROFESSIONAL EXPERIENCE Booz & Company Inc., formerly Booz Allen Hamilton (New York, NY) 01/2010- Date Strategic Management Associate (Health Practice) Booz & Company is a leading global management consulting firm, helping the world 's top businesses, governments, and other institutions. Role in identifying pra ctical solutions to problems within the life sciences sector for projects such a s the following: * Developed a business case for a global pharmaceutical manufacturer seeking div ersification into in vitro diagnostics (IVD) Built a unique, client specific business model that reduced the risk of long-ter m loss from investment decision * Assessed the IVD landscape, defining the most attractive segments for market e ntry * Defined how client should take advantage of high-potential segments * Estimated the potential financial opportunity associated with the target appro ach * Developed acquisition plan for a standalone IVD business to give client maximu m strategic flexibility at minimal cost of entry * Identified and prioritized several acquisition opportunities that could augmen t client capabilities * Proposed financing strategy for public biotech company Constructed company valuation matrices and analyzed various financing scenarios * Conducted "bottom up" and "top down" approaches to enterprise valuation * Identified key valuation inflection points within pipeline development path an d their impact on enterprise valuation * Assessed and prioritized several financing options including pros and cons of each approach (e.g., strategic investment, private equity, component sales and M &A/sale of company) * Within each strategy, identified lead financing candidates ideally suited to c lient's assets and capabilities Acidophil, LLC (Baltimore, MD) 2005- 2009 Principal and Portfolio Project Manager (2007-2009) Analyst (2005-2007) Key member of Acidophil, LLC, a technology innovation and development company co -founded by Nobel Laureate Sydney Brenner and biotechnology entrepreneur Philip Goelet. Acidophil builds new biotechnology companies that use biochemical or mol ecular engineering combined with other technologies to create novel processes an d products. Acidophil is affiliated with Red Abbey Venture Partners. * Opportunity Identification and Strategic Assessment Led scouting and evaluation efforts for multidisciplinary emerging technologies for potential company formation

* Researched and authored current status reports on bio-fuels, diagnostics and t herapeutics in order to identify key areas of unmet need, likely technological a nd strategic solutions and potential for significant commercial upside * Drafted and invented new IP where required and authored 2 company owned patent s * Conducted Intellectual Property (IP), technical and clinical due diligence on ~20 projects * Led primary market research and competitive intelligence efforts for ~20 proje cts * Authored opportunity assessment executive summaries recommending areas for pot ential investment * Company Creation and Early Development Founding member of two companies in the life sciences and clean tech sectors * Drafted business plans (with CEO and COO) * Drafted R&D plans (with scientific co-founders) * Worked with regulatory and clinical consultants to draft clinical development plans * Worked with corporate counsel to assemble company formation documentation * Worked with CEO to recruit COO, key technical business, regulatory and technic al experts * Project Management and Business Development Central role in managing alliances, contracts, consultants and deliverables * Managed cross platform, international R&D teams including biologists, chemists , and engineers in technological advancement efforts * Drafted and managed legal contracts for key consultants and advisors * In-licensed and developed alliances focused around key products and technologi es * Consulted with inventors, entrepreneurs, scientific thought leaders, clinician s and investors * Ensured development plans were implemented timely and within budget constraint s * Raising Independent Capital Participated in presentation of technologies and companies to sources of public and private funding * Identified public, private and strategic sources of funding * Authored research proposals, grants and technical reports * Wrote executive summaries of opportunity offerings for likely investors * Helped with investor and strategic partner presentations * Organized all necessary required due diligence materials for investors and cor porate partners Bayer Corporation (Pittsburgh, PA) 1998-1999 Research and Development Intern * Examined polymer authenticity and materials characterization (analytical physi cs group) * Designed, synthesized and developed chemical catalysts for rapid and efficient polymerization of polycarbonates (corporate research group) EDUCATION PharmaVentures (Oxford, UK) 2006 Business Trainee Participated in internship and workshop at PharmaVentures, a pharmaceutical stra

tegic business consultancy involved in partnering, licensing, acquisitions, dive stments and new business start-up * Business Development and Competitive Intelligence training * Preliminary course in financial modeling and licensing negotiations Johns Hopkins School of Medicine (Baltimore, MD) 2005 Doctor of Philosophy in Cellular and Molecular Medicine Designed, synthesized, investigated, characterized and validated novel cancer ta rgeting and treatment strategies * First prize in clinical and translational research, Johns Hopkins School of Me dicine * Young investigator award, American Association for Cancer Research (<10% of gl obal applicants) * Primary and secondary author in several leading peer-reviewed scientific journ als * Presented thesis work at international meetings in the US and Europe * Lead drug candidate currently under human safety testing, (Phase I clinical tr ials) University of Pittsburgh (Pittsburgh, PA) 1999 Bachelor of Science in Chemistry (Summa Cum Laude - Highest Honors) Chemistry Laboratory Instructor and Teacher's Assistant during junior and senior years * * * * * Chancellor's full scholarship recipient (awarded to top 5% of incoming class) Top 2% in the worldwide chemistry subject standardized aptitude test (SAT) Primary author in Chemical Physics Letters Student athlete academic award (varsity women's basketball) Undergraduate teacher's award

PUBLICATIONS AND REFERENCES AVAILABLE UPON REQUEST